Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Baxter International (NY:BAX)

31.66 +0.62 (+2.00%)
Official Closing Price Updated: 7:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Baxter International

< Previous 1 2 3 4 5 6 7 8 Next >
Baxter Reports Second-Quarter 2024 Results
From Baxter International Inc.
Via Business Wire
Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Baxter publishes annual corporate responsibility report, highlighting continued focus on creating lasting impact
From Baxter International Inc.
Via Business Wire
Baxter International Inc. (NYSE: BAX) Highlighted for Surprising Price Action
Via Investor Brand Network
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
From Baxter International Inc.
Via Business Wire
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
From Baxter International Inc.
Via Business Wire
Baxter to Present at Jefferies 2024 Global Healthcare Conference
From Baxter International Inc.
Via Business Wire
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
From Baxter International Inc.
Via Business Wire
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
From Baxter International Inc.
Via Business Wire
Baxter to Present at Bank of America 2024 Health Care Conference
From Baxter International Inc.
Via Business Wire
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Baxter Reports First-Quarter 2024 Results
From Baxter International Inc.
Via Business Wire
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
From Baxter International Inc.
Via Business Wire
Baxter to Host Annual Meeting of Stockholders in Virtual Format
From Baxter International Inc.
Via Business Wire
Baxter to Present at Raymond James 45th Annual Institutional Investors Conference
From Baxter International Inc.
Via Business Wire
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Baxter Reports Fourth-Quarter and Full-Year 2023 Results
From Baxter International Inc.
Via Business Wire
Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals
From Baxter International Inc.
Via Business Wire
Baxter to Present at 42nd Annual J.P. Morgan Healthcare Conference
From Baxter International Inc.
Via Business Wire
Baxter Publishes Task Force on Climate-Related Financial Disclosures (TCFD) Report and Is Named to Dow Jones Sustainability Index North America
From Baxter International Inc.
Via Business Wire
The Baxter International Foundation and UNICEF Partner to Expand Access to Safe Water and Sanitation in Egypt
From Baxter International Inc.
Via Business Wire
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Baxter Highlights New Data at Kidney Week Indicating Sharesource Is Associated With a 77% Lower Risk of Home Dialysis Technique Failure
From Baxter International Inc.
Via Business Wire
Baxter Reports Third-Quarter 2023 Results
From Baxter International Inc.
Via Business Wire
NYSE:BAX Long Term Investor Alert: Investigation of Potential Wrongdoing at Baxter International Inc.
San Diego, CA -- (SBWIRE) -- 10/23/2023 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Baxter International Inc.. 
Via SBWire
The Value Deepens for Medtech Stocks: Reversal Imminent
MedTech stocks are performing well and supported by pent-up demand, yet share prices are trading at significant and often historical lows. 
Via MarketBeat
Baxter Launches Digital Image Capture Capability for PanOptic Plus Ophthalmoscope
From Baxter International Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

"

"